M. Eric Kohler

2.7k total citations · 1 hit paper
32 papers, 1.8k citations indexed

About

M. Eric Kohler is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, M. Eric Kohler has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in M. Eric Kohler's work include CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (10 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). M. Eric Kohler is often cited by papers focused on CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (10 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). M. Eric Kohler collaborates with scholars based in United States and Canada. M. Eric Kohler's co-authors include Terry J. Fry, Rimas J. Orentas, Kelsey M. Wanhainen, Maria Ingaramo, Crystal L. Mackall, Jillian Smith, Adrienne H. Long, Rosandra N. Kaplan, Meera Murgai and Waleed Haso and has published in prestigious journals such as Nature Medicine, Nature Communications and Blood.

In The Last Decade

M. Eric Kohler

24 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

2015 1.3k citations Adrienne H. Long, Waleed Haso et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Eric Kohler United States	11	1.6k	799	529	507	395	32	1.8k
Monica Casucci Italy	16	1.6k 1.0×	654 0.8×	495 0.9×	527 1.0×	466 1.2×	35	1.9k
Mark B. Leick United States	16	1.4k 0.9×	518 0.6×	505 1.0×	526 1.0×	408 1.0×	47	1.8k
Ignazio Caruana Italy	18	1.4k 0.9×	709 0.9×	488 0.9×	556 1.1×	496 1.3×	35	1.8k
Adrienne H. Long United States	7	1.7k 1.1×	753 0.9×	595 1.1×	553 1.1×	485 1.2×	13	1.9k
Chunmeng Wang China	17	1.3k 0.8×	433 0.5×	343 0.6×	446 0.9×	371 0.9×	32	1.6k
Biagio De Angelis Italy	22	1.2k 0.7×	774 1.0×	326 0.6×	543 1.1×	352 0.9×	44	1.7k
Sang M. Nguyen United States	10	1.2k 0.8×	370 0.5×	437 0.8×	418 0.8×	376 1.0×	16	1.4k
Kelsey M. Wanhainen United States	10	1.7k 1.0×	776 1.0×	582 1.1×	551 1.1×	436 1.1×	14	1.9k
Katherine T. Marcucci United States	13	1.5k 0.9×	498 0.6×	462 0.9×	503 1.0×	543 1.4×	20	1.8k
Christopher C. Kloss United States	11	2.2k 1.4×	925 1.2×	820 1.6×	932 1.8×	679 1.7×	15	2.6k

Countries citing papers authored by M. Eric Kohler

Since Specialization

Citations

This map shows the geographic impact of M. Eric Kohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eric Kohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eric Kohler more than expected).

Fields of papers citing papers by M. Eric Kohler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Eric Kohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eric Kohler. The network helps show where M. Eric Kohler may publish in the future.

Co-authorship network of co-authors of M. Eric Kohler

This figure shows the co-authorship network connecting the top 25 collaborators of M. Eric Kohler. A scholar is included among the top collaborators of M. Eric Kohler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Eric Kohler. M. Eric Kohler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeGolier, Kole, Etienne Danis, Ross M. Kedl, et al.. (2025). Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response. Nature Immunology. 26(1). 68–81. 7 indexed citations

Novak, Amanda J, Etienne Danis, Steven McClellan, et al.. (2025). Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia. Cancer Cell. 43(3). 482–502.e9. 3 indexed citations

Kohler, M. Eric, Kimberly R. Jordan, Angela M. Ohm, et al.. (2025). Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells. PubMed. 33(2). 200981–200981.

Knapp, Jennifer R., M. Eric Kohler, Mayumi Fujita, et al.. (2024). Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity. The Journal of Immunology. 212(8). 1381–1391.

Wu, Meng‐Han, Felipe Valença-Pereira, Francesca Cendali, et al.. (2024). Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies. Nature Communications. 15(1). 4444–4444. 8 indexed citations

Lyons, Kent, Ilaria Iacobucci, Huimin Geng, et al.. (2024). Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 1446–1446.

Verneris, Michael R., Kimberly R. Jordan, Navin Pinto, et al.. (2024). Preliminary Safety and Tolerability of CD19x22 CAR-T Cell Therapy in Adolescent and Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 4510–4510.

Simpson, Haley, et al.. (2024). CD64 CAR-T Therapy Targets Venetoclax-Resistant Monocytic Acute Myeloid Leukemia. Blood. 144(Supplement 1). 3416–3416. 2 indexed citations

Wu, Meng‐Han, Emily Giddings, Felipe Valença-Pereira, et al.. (2024). Abstract 4013: Increasing mitochondrial respiration by silencing MCJ/DnaJC15 enhances CD8 CAR-T cell therapy efficacy. Cancer Research. 84(6_Supplement). 4013–4013.

10.

Marians, Russell, et al.. (2022). Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products. Cytotherapy. 25(1). 94–102. 17 indexed citations

11.

Niswander, Lisa M, Christopher D. Chien, Christina A. Meadows, et al.. (2022). Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemia. Haematologica. 108(2). 457–471. 35 indexed citations

12.

Liao, Wenjuan, M. Eric Kohler, Terry J. Fry, & Patricia Ernst. (2021). Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia. Experimental Hematology. 100. 1–11. 18 indexed citations

13.

Yang, Yinmeng, M. Eric Kohler, & Terry J. Fry. (2017). Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory Formation. Blood. 130. 166–166. 5 indexed citations

14.

Kohler, M. Eric, et al.. (2017). A Direct Comparison of the In Vivo Efficacy and in Vitro Signaling of Chimeric Antigen Receptors and Endogenous T Cell Receptors. Blood. 130. 4451–4451. 4 indexed citations

15.

Long, Adrienne H., Waleed Haso, Jack F. Shern, et al.. (2015). 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nature Medicine. 21(6). 581–590. 1252 indexed citations breakdown →

16.

Kohler, M. Eric, William Hallett, Qingrong Chen, et al.. (2010). Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine. Cellular Immunology. 265(1). 65–73. 4 indexed citations

17.

Kohler, M. Eric, Bryon D. Johnson, Katie Palen, et al.. (2010). Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data. Cancer Science. 101(11). 2316–2324. 5 indexed citations

18.

Zheng, Jin, M. Eric Kohler, Qingrong Chen, et al.. (2007). Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen. BMC Immunology. 8(1). 4–4. 11 indexed citations

19.

Orentas, Rimas J., M. Eric Kohler, & Bryon D. Johnson. (2006). Suppression of anti-cancer immunity by regulatory T cells: Back to the future. Seminars in Cancer Biology. 16(2). 137–149. 53 indexed citations

20.

Stephens, Edward B., et al.. (2003). The Primary Phase of Infection by Pathogenic Simian–Human Immunodeficiency Virus Results in Disruption of the Blood–Brain Barrier. AIDS Research and Human Retroviruses. 19(10). 837–846. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact